EXR
40
-6
AIG
78
-2
NAVI
27
-2
SYK
40
-2
GD
57
-2
CAG
53
-2
LMT
29
-21
NUE
36
-7
HD
40
-3
VTR
54
-6
BXP
46
2
NWS
64
2
UPS
32
-3
MAR
33
-2
STZ
50
-2
AFL
60
-2
PCG
62
-4
FLS
57
-2
NTAP
37
2
DE
58
9
EXR
40
-6
AIG
78
-2
NAVI
27
-2
SYK
40
-2
GD
57
-2
CAG
53
-2
LMT
29
-21
NUE
36
-7
HD
40
-3
VTR
54
-6
BXP
46
2
NWS
64
2
UPS
32
-3
MAR
33
-2
STZ
50
-2
AFL
60
-2
PCG
62
-4
FLS
57
-2
NTAP
37
2
DE
58
9
Financhill
Back

PT Bank Central Asia Tbk Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
26

PBCRF
PT Bank Central Asia Tbk

Last Price:
$0.48
Seasonality Move:
-1.44%
Buy
61

ALNY
Alnylam Pharmaceuticals

Last Price:
$283.22
Seasonality Move:
3.3%
Sell
26
PT Bank Central Asia Tbk (PBCRF) is a Sell

Is PT Bank Central Asia Tbk a Buy, Sell or Hold?

  • The current PT Bank Central Asia Tbk [PBCRF] share price is $0.48. The Score for PBCRF is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • PBCRF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $283.34. The Score for ALNY is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PBCRF Stock Price Chart

What is PT Bank Central Asia Tbk's stock price today?

  • The PT Bank Central Asia Tbk share price today is $0.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBCRF is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $283.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

PBCRF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 38.91 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.5 - 0.56) Sell
Bollinger Bands (100): (0.54 - 0.64) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.81 Buy
Relative Strength Index (14 RSI): 68.89 Buy
Chaikin Money Flow: 1798941 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (239.98 - 259.48) Buy
Bollinger Bands (100): (240.26 - 271.94) Buy

PBCRF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.51 Sell
20-day SMA: 0.52 Sell
50-day SMA: 0.55 Sell
200-day SMA: 0.61 Sell
8-day EMA: 0.5 Sell
20-day EMA: 0.52 Sell
50-day EMA: 0.55 Sell
200-day EMA: 0.6 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 251.71 Buy
20-day SMA: 247.77 Buy
50-day SMA: 256.39 Buy
200-day SMA: 250.79 Buy
8-day EMA: 256.23 Buy
20-day EMA: 252.43 Buy
50-day EMA: 253.95 Buy
200-day EMA: 242.96 Buy

PT Bank Central Asia Tbk Earnings Growth & PBCRF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $0.95 per share, and an increase next year of $2.74 per share.

PT Bank Central Asia Tbk Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):